This week on the FLATLINING Podcast, Matthew and Ron discuss the new weight loss drug by Novo Nordisk (NVO 0.00%↑) called Wegovy and how it and similar drugs could change America’s public health. Plus, they talk about why insurance companies aren’t covering it and how and when that could change.
Subscribe to the FLATLINING Podcast on Apple Podcasts, Spotify, the iHeartRadio app, Amazon Music, Google Podcasts, Stitcher, Pandora, TuneIn, and Audible.
Articles mentioned in this program:
Ozempic Can Cause Major Weight Loss. What Happens if You Stop Taking It? - The New York Times
What to Know About Ozempic, Wegovy and the New Weight-Loss Market - CNET
Covering new weight loss drugs could strain Medicare, policy experts warn - STAT News
Ep. 43 - The hype behind Wegovy